Filtered By:
Condition: Hemorrhagic Stroke
Vaccination: Vaccines
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 80 results found since Jan 2013.
Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France
CONCLUSION: In persons aged 18 to 74 years, adenoviral-based vaccines may be associated with increased incidence of MI and PE. No association between mRNA-based vaccines and the cardiovascular events studied was observed.PRIMARY FUNDING SOURCE: None.PMID:35994748 | DOI:10.7326/M22-0988
Source: Annals of Internal Medicine - August 22, 2022 Category: Internal Medicine Authors: J érémie Botton Marie Joelle Jabagi Marion Bertrand B érangère Baricault J érôme Drouin St éphane Le Vu Alain Weill Paddy Farrington Mahmoud Zureik Rosemary Dray-Spira Source Type: research
Rare Adverse Events Associated with BNT162b2 mRNA Vaccine (Pfizer-BioNTech): A Review of Large-Scale, Controlled Surveillance Studies
In conclusion, this review has concisely summarized the current rare adverse events related and unrelated to BNT162b2, arguably for the first time in sufficient depth, to better communicate vaccine safety to the public.PMID:35891231 | DOI:10.3390/vaccines10071067
Source: Herpes - July 27, 2022 Category: Infectious Diseases Authors: Shin-Jie Yong Alice Halim Michael Halim Abbas Al Mutair Saad Alhumaid Jehad Al-Sihati Hawra Albayat Mohammed Alsaeed Mohammed Garout Reyouf Al Azmi Noor Aldakheel Abeer N Alshukairi Hani A Al Ali Adel A Almoumen Ali A Rabaan Source Type: research
Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans
CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest that there were few differences in risk of adverse events within 14 days of the first dose of either the BNT162b2 or the mRNA-1273 vaccine and small-magnitude differences within 42 days of the first dose. The 38-week risks of adverse events were low in both vaccine groups, although risks were lower for recipients of the mRNA-1273 vaccine than for recipients of the BNT162b2 vaccine. Although the primary analysis was designed to detect safety events unrelated to SARS-CoV-2 infection, the possibility that these differences may partially be explained by a low...
Source: Herpes - June 13, 2022 Category: Infectious Diseases Authors: Barbra A Dickerman Arin L Madenci Hanna Gerlovin Katherine E Kurgansky Jessica K Wise Michael J Figueroa Mu ñiz Brian R Ferolito David R Gagnon J Michael Gaziano Kelly Cho Juan P Casas Miguel A Hern án Source Type: research
Intracranial aneurysm rupture within three days after receiving mRNA anti-COVID-19 vaccination: Three case reports
CONCLUSION: Although the advantages of COVID-19 vaccination appear to outweigh the risks, pharmacovigilance must be maintained to monitor potentially fatal adverse events and identify possible associations.PMID:35509565 | PMC:PMC9062907 | DOI:10.25259/SNI_1144_2021
Source: Surgical Neurology International - May 5, 2022 Category: Neurosurgery Authors: Sotaro Oshida Yosuke Akamatsu Yoshiyasu Matsumoto Taro Suzuki Takuto Sasaki Yuki Kondo Shunrou Fujiwara Hiroshi Kashimura Yoshitaka Kubo Kuniaki Ogasawara Source Type: research
